By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Achillion Pharmaceuticals, Inc. 

300 George Street

New Haven  Connecticut  06511  U.S.A.
Phone: 203-624-7000 Fax: 203-624-7003



Drug Discovery

Company News
Achillion (ACHN) Reports Second Quarter 2017 Financial Results And Proof-Of-Concept With A First-In-Class, Oral Factor D Inhibitor 8/9/2017 12:12:09 PM
Achillion (ACHN) Shares Surge on Promising ACH-4471 Phase II Data 8/9/2017 9:10:03 AM
Achillion (ACHN) To Host Second Quarter 2017 Results Conference Call On August 8, 2017 8/2/2017 11:32:04 AM
Achillion (ACHN) Announces Key Promotion And Discovery Organization Change 7/11/2017 11:20:34 AM
Achillion (ACHN) Reports First Quarter 2017 Financial Results And Provides Update On Clinical Programs 5/4/2017 11:48:48 AM
Achillion (ACHN) Announces Additional Phase II Results Including 100% SVR24 For Genotype 1 HCV After 6-Weeks Of Once Daily JNJ-4178 4/24/2017 8:16:58 AM
Achillion (ACHN) Announces Initiation Of Patient Dosing In Phase II Study Of ACH-4471 For Paroxysmal Nocturnal Hemoglobinuria 4/6/2017 11:18:55 AM
USPTO Grants Composition Of Matter Patent To Achillion (ACHN) For Small Molecule Complement Alternative Pathway Factor D Inhibitors 3/22/2017 8:41:04 AM
Achillion (ACHN) Reports 2016 Fourth Quarter And Year-End Financial Results 2/24/2017 7:55:34 AM
IDBS E-WorkBook For Chemistry Enables Achillion (ACHN) To Go Paperless 2/8/2017 8:22:02 AM